Journal article
Integrated proteomics unveils nuclear PDE3A2 as a regulator of cardiac myocyte hypertrophy
- Abstract:
-
Background: Signaling by cAMP is organized in multiple distinct subcellular nanodomains regulated by cAMP-hydrolyzing PDEs (phosphodiesterases). Cardiac β-adrenergic signaling has served as the prototypical system to elucidate cAMP compartmentalization. Although studies in cardiac myocytes have provided an understanding of the location and properties of a handful of cAMP subcellular compartments, an overall view of the cellular landscape of cAMP nanodomains is missing.
Methods: Here, we combined an integrated phosphoproteomics approach that takes advantage of the unique role that individual PDEs play in the control of local cAMP, with network analysis to identify previously unrecognized cAMP nanodomains associated with β-adrenergic stimulation. We then validated the composition and function of one of these nanodomains using biochemical, pharmacological, and genetic approaches and cardiac myocytes from both rodents and humans.
Results: We demonstrate the validity of the integrated phosphoproteomic strategy to pinpoint the location and provide critical cues to determine the function of previously unknown cAMP nanodomains. We characterize in detail one such compartment and demonstrate that the PDE3A2 isoform operates in a nuclear nanodomain that involves SMAD4 (SMAD family member 4) and HDAC-1 (histone deacetylase 1). Inhibition of PDE3 results in increased HDAC-1 phosphorylation, leading to inhibition of its deacetylase activity, derepression of gene transcription, and cardiac myocyte hypertrophic growth.
Conclusions: We developed a strategy for detailed mapping of subcellular PDE-specific cAMP nanodomains. Our findings reveal a mechanism that explains the negative long-term clinical outcome observed in patients with heart failure treated with PDE3 inhibitors.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 5.4MB, Terms of use)
-
- Publisher copy:
- 10.1161/circresaha.122.321448
Authors
- Publisher:
- American Heart Association
- Journal:
- Circulation Research More from this journal
- Volume:
- 132
- Issue:
- 7
- Pages:
- 828-848
- Publication date:
- 2023-03-08
- Acceptance date:
- 2023-03-01
- DOI:
- EISSN:
-
1524-4571
- ISSN:
-
0009-7330
- Pmid:
-
36883446
- Language:
-
English
- Keywords:
- Pubs id:
-
1331767
- Local pid:
-
pubs:1331767
- Deposit date:
-
2023-09-07
- ARK identifier:
Terms of use
- Copyright holder:
- Subramaniam et al.
- Copyright date:
- 2023
- Rights statement:
- © 2023 The Authors. Circulation Research is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record